Clinical Trials Logo
  1. Home
  2. Respiratory Complication
  3. NCT01915108

Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal

Respiratory Complication Clinical Trial

Official title:
Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal During Emergence From Sevoflurane-remifentanil Anesthesia

Clinical Trial Summary

This study was designed to determine the optimal dose of remifentanil that can prevent the complications associated with the removal of LMA without delaying emergence.

Clinical Trial Description

Patients were randomly assigned to one of four groups. All patients received a predetermined effect-site concentrations (Ce) of remifentanil by target-controlled infusion (TCI) according to their group assignments (R0, remifentanil Ce of 0 ng/ml; R0.5, remifentanil Ce of 0.5 ng/ml; R1.0, remifentanil Ce of 1.0 ng/ml; R1.5, remifentanil Ce of 1.5 ng/ml) from 10 minutes before the end of surgery to LMA removal. Airway complications (airway obstruction, desaturation, breath holding, and coughing), nausea, and vomiting were assessed during the emergence phase. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01915108
Study type Interventional
Source Yeungnam University College of Medicine
Contact
Status Completed
Phase N/A
Start date July 2012
Completion date June 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT03946137 - Chest Therapy and Postural Education in Children With Cerebral Palsy N/A
Recruiting NCT06089226 - Parameters Related to Physical Activity Level in SCI
Completed NCT03931902 - The Comparison of Laryngeal Mask Airway and Endotracheal Tube in General Anesthesia for Premature Neonates N/A
Completed NCT03105739 - Timing of Withdrawal of the Laryngeal Mask Airway (LMA) in Children N/A
Recruiting NCT04100512 - Oscillating Positive Expiratory Pressure (OPEP) Therapy in Trauma Patients With Multiple Rib Fractures N/A
Enrolling by invitation NCT06360666 - Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Completed NCT03056885 - Inflammatory Local Response During OLV: Protective vs Conventional Ventilation Strategy N/A
Recruiting NCT05136781 - DEXAMETHASONE for Non-urgent Thoracic Surgery
Terminated NCT03665259 - Lower Inspiratory Oxygen Fraction for Preoxygenation N/A
Not yet recruiting NCT03255356 - Ventilation in Cardiac Surgery N/A
Terminated NCT03571646 - LIFEGUARD Study - Continuous Respiratory Monitoring on the General Ward N/A
Not yet recruiting NCT05363098 - The Cerebral-Respiratory Interaction During Spontaneous Breathing Ventilation in Neurosurgical Patients (CeRes-SB)
Recruiting NCT03969147 - Investigation of a Novel Oropharyngeal Airway: The ManMaxAirway N/A
Completed NCT03218215 - Monitoring Mechanical Assisted Cough N/A
Completed NCT03102619 - Wireless Assessment of Respiratory and Circulatory Distress; A Pilot Study N/A
Recruiting NCT05804175 - Advanced Prediction of Respiratory Depression Episode With the Linshom Continuous Predictive Respiratory Sensor
Recruiting NCT06301126 - Virtual Reality on Pulmonary Function After Upper Abdominal Surgeries N/A
Recruiting NCT05354466 - Perioperative Respiratory Adverse events_sugammadex N/A
Recruiting NCT05856136 - A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle Phase 4